Atea Pharmaceuticals Inc (AVIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 0 | 0 | 351,367 | 48,633 |
| Gross Profit | N/A | N/A | N/A | 351,367 | 48,633 |
| Operating Expenses | 192,950 | 164,162 | 130,650 | 212,990 | 59,663 |
| Operating Income | -192,950 | -164,162 | -130,650 | 138,377 | -11,030 |
| Other Income | 25,490 | 29,224 | 11,151 | 213 | 83 |
| Pre-tax Income | -167,460 | -134,938 | -119,499 | 138,590 | -10,947 |
| Income Tax | 925 | 1,018 | -3,590 | 17,400 | N/A |
| Net Income Continuous | -168,385 | -135,956 | -115,909 | 121,190 | -10,947 |
| Net Income | $-168,385 | $-135,956 | $-115,909 | $121,190 | $-10,947 |
| EPS Basic Total Ops | -2.00 | -1.63 | -1.39 | 1.46 | -0.51 |
| EPS Basic Continuous Ops | -2.00 | -1.63 | -1.39 | 1.46 | -0.51 |
| EPS Diluted Total Ops | -2.00 | -1.63 | -1.39 | 1.37 | -0.51 |
| EPS Diluted Continuous Ops | -2.00 | -1.63 | -1.39 | 1.37 | -0.51 |
| EPS Diluted Before Non-Recurring Items | -2.00 | -1.63 | -1.39 | 1.37 | -0.51 |
| EBITDA(a) | $-204,355 | $-179,192 | $-135,855 | $138,406 | $-11,011 |